News & Events

News

TSO3 Reports Fourth Quarter and Full Year 2017 Results

Quebec City, Canada and Myrtle Beach, United States, – March 20, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for the fourth quarter and year ended December 31, 2017.

Read more

TSO3 Submits Response to US Regulators in Support of Terminal Sterilization of Duodenoscopes

Quebec City, Canada and Myrtle Beach, United States, March 19, 2018 – TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, today announced that it has provided its final Additional Information (AI) response to US Regulators in support of extending the claims of the Company’s STERIZONE® VP4 Sterilizer to include the terminal sterilization of duodenoscopes.

Read more

TSO3’s STERIZONE® VP4 Sterilizer Receives 510(k) Clearance

Quebec City, Canada and Myrtle Beach, United States, March 14, 2018 – TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, today announced that it has received 510(k) clearance from US regulators for a significant improvement to its STERIZONE® VP4 Sterilizer. The cleared change can improve the customer installation process and reduce start-up costs by significantly reducing the oxygen supply requirements for the system.

Read more

TSO3 Sets Fourth Quarter and Full Year 2017 Earnings Call for Wednesday, March 21, 2018 at 8:30 a.m. EDT

Quebec City, Canada and Myrtle Beach, United States, – March 7, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, March 21, 2018, to discuss its financial results for the fourth quarter and full year ended December 31, 2017. Financial results will be issued in a press release prior to the call.

Read more

TSO3 to Present at the RBC Capital Markets Healthcare Conference

Quebec City, Canada and Myrtle Beach, United States, February 14, 2018 – TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, today announced the Company will participate in the RBC Capital Markets Healthcare Conference in New York, New York

Read more